This randomized , multicenter trial conducted from April 26 , 2012 , through April 9 , 2014 , in 8 countries consisted of 4 phases : 3-week screening phase , flexible-dose 17-week open-label transition phase , 12-week open-label maintenance phase , and open-ended double-blind ( DB ) phase .